Two Sigma Advisers
YTEN

Two Sigma Advisers’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Two Sigma Advisers’s Portfolio YTEN Stock Details YTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-967
Closed -$198K – 2739
2021
Q2 		$198K Buy
967
+238
+33% +$53K ﹤0.01% 2272
2021
Q1 		$219K Buy
+729
New +$247K ﹤0.01% 2336

Other funds holding YTEN

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Two Sigma Advisers's YTEN Position: Q3 2021 in Review

Two Sigma Advisers sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q3 2021, closing a stake of 967 shares — an estimated $198K sold.

Two Sigma Advisers first reported a position in YTEN in Q1 2021 and held it in 2 quarters. The position peaked at $219K in Q1 2021. 13 funds tracked by Wall St. Rank hold YTEN as of Q3 2021.

  • Two Sigma Advisers reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Two Sigma Advisers sold 967 Yield10 Bioscience, Inc. Common Stock shares in Q3 2021, an estimated $198K.
  • Two Sigma Advisers first reported a position in Yield10 Bioscience, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Two Sigma Advisers's Yield10 Bioscience, Inc. Common Stock position peaked at $219K in Q1 2021.
  • 13 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q3 2021.

Based on Two Sigma Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.